Advertisement
UK markets closed

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     

  • AIM

    755.28
    +2.16 (+0.29%)
     

  • GBP/EUR

    1.1672
    +0.0016 (+0.14%)
     

  • GBP/USD

    1.2481
    -0.0030 (-0.24%)
     

  • Bitcoin GBP

    51,034.08
    -358.82 (-0.70%)
     

  • CMC Crypto 200

    1,321.75
    -74.78 (-5.35%)
     

  • S&P 500

    5,102.62
    +54.20 (+1.07%)
     

  • DOW

    38,244.53
    +158.73 (+0.42%)
     

  • CRUDE OIL

    84.07
    +0.50 (+0.60%)
     

  • GOLD FUTURES

    2,348.20
    +5.70 (+0.24%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

BUZZ-Smiths: FT reports activist firm ValueAct has stake in co

Reuters - UK Focus

** Smiths Group (Other OTC: SMGKF - news) seen up 3-5 pct after FT reports U.S. activist investor ValueAct has stake in the British engineering conglomerate

** The daily quotes sources as saying that ValueAct views Smiths' medical devices unit and its John Crane seals unit as potential M&A targets (http://bit.ly/1SWRfze)

** ValueAct could not be immediately be reached for comment outside of regular business hours in the U.S.

** Spokesman for Smiths declines to disclose individual shareholdings below statutory disclosure levels

** Smiths said in September it was not planning to sell the ailing medical unit, where suffering margins have prompted calls for a sale; shares have slid 9 pct since

ADVERTISEMENT

** Based on Monday's close, Smiths would have to rise c.17 pct to reach StarMine intrinsic value estimate

** The report on ValueAct a few days after the activist fund reported a stake in Rolls-Royce (RM (LSE: RM.L - news) : esha.vaish.thomsonreuters.com@reuters.net)